INNO-206 in Patients With Small Cell Lung Cancer (SCLC)

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 31, 2008

Study Completion Date

November 30, 2008

Conditions
Small Cell Lung Cancer
Interventions
DRUG

INNO-206

Trial Locations (7)

12206

New York Oncology Hematology, P.C., Albany

29605

Cancer Centers of the Carolinas, Greenville

45042

Signal Point Hematology/Oncology, Inc., Middletown

45409

Dayton Oncology and Hematology, Kettering

59107

Billings Clinic, Billings

60637

University of Chicago, Chicago

75246

Mary Crowley Medical Research Center, Dallas

Sponsors

Lead Sponsor

All Listed Sponsors
lead

CytRx

INDUSTRY

NCT00472771 - INNO-206 in Patients With Small Cell Lung Cancer (SCLC) | Biotech Hunter | Biotech Hunter